Dithi Banerjee - Concepedia

Author

Dithi Banerjee

Also Known As

Andrew M. Atz, Annabelle Goetter, Banerjee D., Banerjee, Dithi, D Banerjee, D. Banerjee, D.K. Banerjee, Dithi Banerjee, Vasanthi Avadhanula

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Children's Mercy Hospital Medical College of Wisconsin Northwestern University University at Buffalo, State University of New York West Virginia University

About

Dithi Banerjee is an author at Children's Mercy Hospital specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	568
2	Engineering	1	1	13
3	Natural Sciences	1	1	29
4	Public Health	1	1	174
5	Biochemistry	1	1	29

Dithi Banerjee

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, JAMA	2023	792
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 Heidi L. Moline, Ayzsa Tannis, Ariana P. Toepfer, MMWR Morbidity and Mortality Weekly Report Respiratory Virus ImmunityVirus EpidemiologyRespiratory ComplicationsPediatric Lung DiseaseOctober 2023–February	2024	174
Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine Todd Bradley, Elin Grundberg, Rangaraj Selvarangan, New England Journal of Medicine VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetImmunology	2021	167
Underdiagnosis of asthma in the elderly Dithi Banerjee, G.S. Lee, Sajjad Malik, British Journal of Diseases of the Chest AsthmaPulmonary CareGeriatricsRespiratory DiseasesPulmonary Medicine	1987	142
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals Elizabeth Fraley, Cas LeMaster, Eric S. Geanes, BMC Medicine	2021	63
Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children Dithi Banerjee, Neena Kanwar, Ferdaus Hassan, Journal of Clinical Microbiology	2018	59
Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range Konner Winkley, Dithi Banerjee, Todd Bradley, Scientific Reports	2021	30
Opposing PKA and Hog1 signals control the post‐transcriptional response to glucose availability in <i>Cryptococcus neoformans</i> Dithi Banerjee, Amanda L. M. Bloom, John C. Panepinto Molecular Microbiology Fungal Cell BiologyBacteriologyMicrobial PhysiologyProtein SynthesisCryptococcus Neoformans	2016	29
Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B Dithi Banerjee, Lauren Burkard, John C. Panepinto PLoS ONE	2014	25
Randomized, Double-Blind Study in Healthy Adults to Assess the Boosting Effect of Vaqta or Havrix after a Single Dose of Havrix Bradley A. Connor, John Phair, David A. Sack, Clinical Infectious Diseases	2001	23

Page 1